At a glance
ClinicalIndex Comparison RecordN/ACompleted· 621 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Gender-based Differences in the Outcome of the Treatment of Persistent Septic Shock With Hydrocortisone
In Brief
An observational study for Septic Shock. Completed, enrolled 621 participants across 1 site.
Detailed Summary
The aim of this study is to explore the gender-based differences in the outcomes of treatment with hydrocortisone in critically ill patients with persistent septic shock.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Shock
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartJan 2023
Primary CompletionJul 2023
Study CompletionAug 2024
First PostedAug 2024
TodayJul 2026
First PostedAug 5, 2024
Enrollment StartJan 1, 2023
Primary CompletionJul 30, 2023
Study CompletionAug 1, 2024
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 1.9 years ago